Careers Media center Contacts

Arterium Corporation launches a new product

Arterium Corporation launches a new product

31 January 2020 | News

In early January, Arterium Corporation launched Argilife, a new generic prescription drug. The new addition is a blood substitute, and its active ingredient is L-arginine, an amino acid that plays a substantial role in the regulation of bodily functions on the cellular level and exhibits protective properties important in critical conditions.

“The application of amino acids in the treatment of heart diseases and in the combination therapy of other conditions has gained utmost relevance these days,” Arterium's project portfolio manager Valentina Plashchevataya said. “Developing this drug, we had to be careful about selecting the active ingredient. We managed to make Argilife a high-quality product that is totally on par with the original,” she added.

Media gallery

Here you can find general information about the company intended for journalists and other stakeholders


For all media-related enquiries,
please contact us
mob.: +38050 446 71 20, +38095 278 92 80